Two decades of liver resection with a multidisciplinary approach in a single institution: What has changed? Analysis of 1409 cases

Carregando...
Imagem de Miniatura
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER ESPANA
Citação
CLINICS, v.77, article ID 100088, 8p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: To evaluate results of patients undergoing liver resection in a single center over the past two decades with a particular look at Colorectal Liver Metastasis (CRLM) and Hepatocellular Carcinoma (HCC). Method: Patients were divided into two eras, from 2000 to 2010 (Era 1) and 2011 to 2020 (Era 2). The most frequent diagnosis was CRLM and HCC, with 738 (52.4%) and 227 (16.1%) cases respectively. An evaluation of all liver resection cases and a subgroup analysis of both CRLM and HCC were performed. Preoperative and per operative variables and long-term outcomes were evaluated. Results: 1409 liver resections were performed. In Era 2 the authors observed higher BMI, more: minimally invasive surgeries, Pringle maneuvers, and minor liver resections; and less transfusion, less ICU necessity, and shorter length of hospital stay. Severe complications were observed in 14.7% of patients, and 90-day mortality was 4.2%. Morbidity and mortality between eras were not different. From 738 CRLM resections, in Era 2 there were significantly more patients submitted to neoadjuvant chemotherapy, bilateral metastases, and smaller sizes with significantly less transfusion, the necessity of ICU, and shorter length of hospital stay. More pedicle clamping, minimally invasive surgeries, and minor resections were also observed. From 227 HCC resections, in Era 2 significantly more minimally invasive surgeries, fewer transfusions, less necessity of ICU, and shorter length of hospital stay were observed. OS was not different between eras for CRLM and HCC. Conclusions: Surgical resection in a multidisciplinary environment remains the cornerstone for the curative treatment of primary and metastatic liver tumors.
Palavras-chave
Hepatectomy, Liver neoplasms, Hepatocellular carcinoma, Colorectal liver metastases, Morbidity
Referências
  1. Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16
  2. Adam R, 2000, ANN SURG, V232, P777, DOI 10.1097/00000658-200012000-00006
  3. Adam R, 2008, J CLIN ONCOL, V26, P1635, DOI 10.1200/JCO.2007.13.7471
  4. Adam R, 2019, ANN GASTROENT SURG, V3, P50, DOI 10.1002/ags3.12227
  5. Adam R, 2012, ONCOLOGIST, V17, P1225, DOI 10.1634/theoncologist.2012-0121
  6. Aldrighetti L, 2015, UPDATES SURG, V67, P129, DOI 10.1007/s13304-015-0307-2
  7. Andres A, 2008, ANN SURG ONCOL, V15, P134, DOI 10.1245/s10434-007-9607-1
  8. [Anonymous], 2017, NEW ENGL J MED, V377, P13, DOI [10.1056/NEJMoa1614362, DOI 10.1056/NEJMOA1614362]
  9. Blazer DG, 2008, J CLIN ONCOL, V26, P5344, DOI 10.1200/JCO.2008.17.5299
  10. Coelho FF, 2016, WORLD J GASTRO SURG, V8, P5, DOI 10.4240/wjgs.v8.i1.5
  11. Cremolini C, 2015, NAT REV CLIN ONCOL, V12, P607, DOI 10.1038/nrclinonc.2015.129
  12. Day RW, 2016, SURGERY, V159, P793, DOI 10.1016/j.surg.2015.10.006
  13. Eguchi S, WORLD J SURG, V45, P1152
  14. European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019
  15. Famularo S, 2021, J GASTROINTEST SURG
  16. Foster J H, 1977, Major Probl Clin Surg, V22, P1
  17. Fretland AA, 2018, ANN SURG, V267, P199, DOI 10.1097/SLA.0000000000002353
  18. Gelli M, 2020, ANN SURG, V272, P820, DOI 10.1097/SLA.0000000000004259
  19. Gold JS, 2008, ANN SURG, V247, P109, DOI 10.1097/SLA.0b013e3181557e47
  20. Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
  21. HERMAN Paulo, 2016, Arq. Gastroenterol., V53, P169, DOI 10.1590/S0004-28032016000300009
  22. Herman P, 2010, J LAPAROENDOSC ADV S, V20, P35, DOI 10.1089/lap.2009.0215
  23. Hobeika C, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100153
  24. House MG, 2010, J AM COLL SURGEONS, V210, P744, DOI 10.1016/j.jamcollsurg.2009.12.040
  25. Jaeck D, 2004, ANN SURG, V240, P1037, DOI 10.1097/01.sla.0000145965.86383.89
  26. Jamagin WR, 2002, ANN SURG, V236, P397, DOI 10.1097/01.SLA.0000029003.66466.B3
  27. Kamiyama T, 2010, J AM COLL SURGEONS, V211, P443, DOI 10.1016/j.jamcollsurg.2010.06.005
  28. Kawaguchi Y, 2021, J GASTROINTEST SURG
  29. Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278
  30. Kruger JAP, 2018, J SURG ONCOL, V118, P50, DOI 10.1002/jso.25098
  31. Longchamp G, 2021, HPB, V23, P645, DOI 10.1016/j.hpb.2020.12.009
  32. Machairas N, 2021, LANGENBECK ARCH SURG, V406, P2151, DOI 10.1007/s00423-021-02298-3
  33. Madoff DC, 2020, CURR ONCOL REP, V22, DOI 10.1007/s11912-020-00922-x
  34. Mise Y, 2016, ANN SURG, V263, P146, DOI 10.1097/SLA.0000000000001194
  35. Nordlinger B, 2013, LANCET ONCOL, V14, P1208, DOI 10.1016/S1470-2045(13)70447-9
  36. Palavecino M, 2010, SURGERY, V147, P40, DOI 10.1016/j.surg.2009.06.027
  37. Pekolj J, 2020, WORLD J SURG, V44, P3868, DOI 10.1007/s00268-020-05646-4
  38. Poon RT, 2004, ANN SURG, V240, P698, DOI 10.1097/01.sla.0000141195.66155.0c
  39. Rhu J, 2018, ANN SURG TREAT RES, V95, P258, DOI 10.4174/astr.2018.95.5.258
  40. Roayaie S, 2015, HEPATOLOGY, V62, P440, DOI 10.1002/hep.27745
  41. Schiergens TS, 2015, DIS COLON RECTUM, V58, P74, DOI 10.1097/DCR.0000000000000233
  42. Sivesgaard K, 2018, EUR RADIOL, V28, P4735, DOI 10.1007/s00330-018-5469-0
  43. Torzilli G, 2021, BRIT J SURG, V108, P109, DOI 10.1093/bjs/znaa112
  44. Tsilimigras DI, 2020, ANN SURG ONCOL, V27, P3318, DOI 10.1245/s10434-020-08548-w
  45. Wakabayashi G, 2015, ANN SURG, V261, P619, DOI [10.1097/SLA.0000000000001180, 10.1097/SLA.0000000000001184]
  46. Zorzi D, 2007, BRIT J SURG, V94, P274, DOI 10.1002/bjs.5719